Cargando…

Guidelines Have a Key Role in Driving HCV Elimination by Advocating for Simple HCV Care Pathways

The availability of pangenotypic direct-acting antivirals for treatment of hepatitis C (HCV) has provided an opportunity to simplify patient pathways. Recent clinical practice guidelines have recognised the need for simplification to ensure that elimination of HCV as a public health concern remains...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mangia, Alessandra, Albanese, Anthony P., Bourliére, Marc, Craxi, Antonio, Dieterich, Douglas, Solomon, Sunil, Vanstraelen, Kim, Hernandez, Candido, Turnes, Juan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884205/ https://www.ncbi.nlm.nih.gov/pubmed/33590446 http://dx.doi.org/10.1007/s12325-021-01636-7

Ejemplares similares

HCV cure without interferon
por: Bourlière, Marc
Publicado: (2014)

New anti HCV drugs in the pipeline
por: Bourlière, Marc
Publicado: (2010)

Role of community‐based research in advocating HCV prevention and care
por: Carrieri, Patrizia, et al.
Publicado: (2017)

Impact of COVID-19 on global HCV elimination efforts
por: Blach, Sarah, et al.
Publicado: (2021)

Global real‐world evidence of sofosbuvir/velpatasvir as simple, effective HCV treatment: Analysis of 5552 patients from 12 cohorts
por: Mangia, Alessandra, et al.
Publicado: (2020)

Is HCV elimination possible in prison?
por: Crespo, J., et al.
Publicado: (2017)

Remaining challenges in HCV elimination
por: Capraru, Camelia, et al.
Publicado: (2021)

Elimination of HCV in Russia: Barriers and Perspective
por: Isakov, Vasily, et al.
Publicado: (2022)

Key Elements on the Pathway to HCV Elimination: Lessons Learned From the AASLD HCV Special Interest Group 2020
por: Feld, Jordan J., et al.
Publicado: (2021)

Meet–Test–Treat for HCV management: patients’ and clinicians’ preferences in hospital and drug addiction services in Italy
por: Andreoni, Massimo, et al.
Publicado: (2022)

Will the COVID-19 pandemic affect HCV disease burden?
por: Kondili, Loreta A., et al.
Publicado: (2020)

Epidemiology and Elimination of HCV-Related Liver Disease
por: Pradat, Pierre, et al.
Publicado: (2018)

Eliminating HCV: a marathon, not a sprint
por: The Lancet Gastroenterology & Hepatology
Publicado: (2020)

Key Role of Multidisciplinary Collaboration towards Global Elimination of HCV Infection
por: Krekulova, Laura, et al.
Publicado: (2022)

Perspectives of hepatitis C virus (HCV) elimination in Poland
por: Flisiak, Robert, et al.
Publicado: (2019)

Impact of the COVID-19 pandemic on HCV elimination in Spain
por: Buti, Maria, et al.
Publicado: (2021)

HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes
por: Garbuglia, Anna Rosa, et al.
Publicado: (2014)

The correlation of HCV RNA and HCV core antigen in different genotypes of HCV
por: Xiang, Yu, et al.
Publicado: (2018)

HCV Elimination in Central Europe with Particular Emphasis on Microelimination in Prisons
por: Flisiak, Robert, et al.
Publicado: (2022)

Outcomes of an HCV elimination program targeting the Viennese MSM population
por: Jachs, Mathias, et al.
Publicado: (2021)

HCV and Oxidative Stress: Implications for HCV Life Cycle and HCV-Associated Pathogenesis
por: Medvedev, Regina, et al.
Publicado: (2016)

Addressing HCV Elimination Barriers in Italy: Healthcare Resource Utilization and Cost Impact Using 8 Weeks’ Glecaprevir/Pibrentasvir Therapy
por: Andreoni, Massimo, et al.
Publicado: (2021)

HCV and lichen planus: HCV and lichen planus
por: Rebora, Alfredo
Publicado: (2011)

Are We on the Right Track for HCV Micro-Elimination? HCV Management Practices in Dialysis Centers in Poland—A National Cross-Sectional Survey
por: Czarnecka, Paulina, et al.
Publicado: (2023)

355. Barriers for Hepatitis C Elimination in HIV/HCV Coinfected Patients
por: Espinoza, Joe, et al.
Publicado: (2019)

Effect of combined siRNA of HCV E2 gene and HCV receptors against HCV
por: Jahan, Shah, et al.
Publicado: (2011)

Key Milestones in HCV Discovery and Therapeutics
por: Cheng, Xiaoming, et al.
Publicado: (2020)

The Burgeoning HIV/HCV Syndemic in the Urban Northeast: HCV, HIV, and HIV/HCV Coinfection in an Urban Setting
por: Morano, Jamie P., et al.
Publicado: (2013)

Effectiveness of HCV core antigen and RNA quantification in HCV-infected and HCV/HIV-1-coinfected patients
por: Long, Lu, et al.
Publicado: (2014)

HCV core antigen plays an important role in the fight against HCV as an alternative to HCV‐RNA detection
por: Wang, Yuhan, et al.
Publicado: (2021)

HIV/HCV co-infection and associated risk factors among injecting drug users in Dar es Salaam, Tanzania: potential for HCV elimination
por: Leyna, Germana Henry, et al.
Publicado: (2019)

HCV resistance
por: Halfon, Philippe
Publicado: (2012)

HCV and Lymphoproliferation
por: Zignego, Anna Linda, et al.
Publicado: (2012)

HCV elimination among people who inject drugs. Modelling pre- and post–WHO elimination era
por: Gountas, Ilias, et al.
Publicado: (2018)

LncRNAs in HCV Infection and HCV-Related Liver Disease
por: Unfried, Juan P., et al.
Publicado: (2020)

RNA editing blood biomarkers for predicting mood alterations in HCV patients
por: Salvetat, N., et al.
Publicado: (2019)

Detection of HCV-Specific IFN-γ Responses in HCV Antibody and HCV RNA Negative Injecting Drug Users
por: Flynn, Jacqueline K, et al.
Publicado: (2014)

Hepatitis C (HCV) therapy for HCV mono-infected and HIV-HCV co-infected individuals living in Nepal
por: KC, Sudhamshu, et al.
Publicado: (2020)

Progress toward implementing the Swiss Hepatitis Strategy: Is HCV elimination possible by 2030?
por: Müllhaupt, Beat, et al.
Publicado: (2018)

HCV treatment in 2020: How to translate highly effective therapies into elimination strategies
por: Alshuwaykh, Omar, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hmrf48jh0tu65iqob5g1532lvp